A Comparative Safety and Pharmacokinetic Study of JHL1922 and Pulmozyme® in Healthy Subjects
Clinical trial NCT03586076 · COMPLETED
Trial details
- NCT number
- NCT03586076
- Sponsor
- JHL Biotech, Inc.
- Status
- COMPLETED
- Phase
- Phase 1
- Study type
- INTERVENTIONAL
- Start date
- 2018-01-26
- Primary completion
- 2018-06-22
- Enrollment
- 24
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.